ACAD
ACADIA Pharmaceuticals Inc
$25.48
0.27 (1.09%) Today
— up— down
Market Cap
$4.32B+18.0%
Revenue (TTM)
$1.09B-13.6%
Net Income (TTM)
$374.74M+87.5%
EPS (TTM)
2.19+87.5%
Shares Out
171.24M
171.24MP/E Ratio
11.64
11.64Forward P/E
38.54
38.54Open
$25.32
$25.32Previous Close
$25.20
$25.20Day Range
$25.16 – $25.62
$25.16 – $25.6252-Week Range
$19.69 – $28.35
$19.69 – $28.35Beta
0.81
0.81Volume
275.97K
275.97KAvg Volume
1.81M
1.81MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ACAD
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Related
News
Acadia Pharmaceuticals: Steady Commercial Progress, Remlifanserin Data In Focus
SeekingAlpha · 1d ago
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $35
Benzinga · 1d ago
Canaccord Genuity Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $36
Benzinga · 1d ago
Acadia Pharma Stock Jumps After European Panel Reverses Course On Rett Syndrome Therapy
Benzinga · 4d ago
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
Benzinga · 4d ago